Oct. 14 at 1:31 PM
BioAdaptives, Inc. (OTC:
$BDPT) is innovating in the wellness and biotech space — blending plant, algal, and mushroom-based ingredients with medical devices to support human and animal health.
Recent product rollouts include MyndMed™ for cognitive support and PawPa™ Regen for pets, signaling the company’s push into both human and animal wellness markets.
At current levels (around the
$0.05 range) and with micro-cap status,
$BDPT represents a high-risk, high-potential-reward opportunity.
If you're comfortable with volatility, this is a name to keep on your radar.